ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical efficacy evaluation and potential mechanism prediction on Guizhi-Shaoyao-Zhimu decoction in the treatment of gouty arthritis based on meta-analysis, network pharmacology analysis, and molecular docking

Qu, Pengda; Wang, Haiyang; Wang, Wei; Hu, Qian; Du, Shiyu; Peng, Zhaorong; Tang, Xiaohu*云南大学; 1
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-11-24DOI: 10.1097/MD.0000000000035973
8阅读
引用收藏
分享

摘要

Background:Guizhi-Shaoyao-Zhimu decoction (GSZD) is a Chinese herb formula. Previous studies have reported that the clinical symptoms and laboratory indicators of gouty arthritis patients could be improved by GSZD. However, no previous study has evaluated and analyzed its efficacy, safety, underlying mechanisms, and the relationship between related ingredients of herbs and targets of gouty arthritis.Methods:Randomized controlled trials of GSZD for gouty arthritis were retrieved from various databases. Meta-analysis was performed by Stata 17 software. Galbraith plot was used to find studies with possible heterogeneity. Publication bias was assessed by Egger test and funnel plot. The related ingredients of herbs and the targets of herbs and gouty arthritis were obtained from several databases, such as TCMSP, HERB, and DrugBank. The protein-protein interaction network was conducted by the STRING platform. DAVID database was used to perform GO and KEGG analysis. Molecular docking and visualization of docking results were carried out by AutoDock and PyMOL software.Results:Twenty studies with 1633 patients were included. Meta-analysis indicated that GSZD could better improve the clinical efficiency and visual analogue scale score, and reduce the level of blood uric acid and inflammatory biomarkers (including C-reactive protein, erythrocyte sedimentation rate, interleukin 6, interleukin 8, and tumor necrosis factor-alpha) than conventional treatment. In addition, we retrieved 157 active compounds, 517 herb target genes, 3082 disease targets, and 295 intersection targets of herb and disease. The results of network pharmacology analysis showed that the core related ingredients included quercetin, kaempferol, sitosterol, luteolin, catechin, etc. The core intersection targets contained AKT1, TNF-alpha, TP53, IL6, etc. And the critical signaling pathways included IL-17, HIF-1, TNF, PI3K-Akt, etc. Among the 56 molecular docking results, only 8 results had binding energy values greater than -5.0 kcal/mol.Conclusion:GSZD could be a satisfactory complementary and alternative therapy for treating gouty arthritis. However, it should be verified by further studies. Future research on gouty arthritis could be conducted from the active components including beta-sitosterol and sitosterol, the targets including TNF-1, IL1B, and ESR1, and the signaling pathways including IL-17 and HIF-1.

学科与关键词

关键词
gouty arthritisGuizhi-Shaoyao-Zhimu decoctionmeta-analysismolecular dockingnetwork pharmacologytraditional Chinese medicine
相关
加载中…
  • Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking
    Qu, Pengda; Du, Shiyu; Wang, Wei; Peng, Zhaorong; Hu, Qian; Wang, Haiyang; Tang, Xiaohu*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2024, 103(1): e36722.
  • Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments
    Zeng, Liying; Lin, Zekun; Kang, Pan; Zhang, Meng; Tang, Hongyu; Li, Miao; Xu, Kun; Liu, Yamei; Jiang, Ziyun*; Huo, Shaochuan*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 2322417.被引 1
  • Bioinformatic assay reveal the potential mechanism of Guizhi-Shaoyao-Zhimu decoction against rheumatoid arthritis and mild-to-moderate COVID-19
    Xu, Yongyu; Huang, Zebin; Wu, Guangping; Jin, Fujun; Lin, Shuojia; Zhang, Chuang; Zheng, Jie; Liu, Wenjie; Hou, Jinqiang; Lu, Yu-Jing*Computer Methods and Programs in Biomedicine, 2023, 238: 107584.
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-11-24
卷期
第 102 卷, 第 47 期
页码
e35973
DOI
10.1097/MD.0000000000035973
语言
ENGLISH
成果收录
SCIE
资助标注
Famous Doctor Special Project for Ten Thousand Talent Plans of Yunnan Province [2022YB02]; Yunnan Provincial Department of Education Science Research Fund Project [1]; Project of first-class discipline construction in Yunnan Province [2022Y362]

作者

  • Q

    Qu, Pengda (第一作者)

    1 · yunnan univ

  • W

    Wang, Haiyang

    1 · yunnan univ

查看全部 7 位作者收起作者
  • W

    Wang, Wei

    yunnan univ

  • H

    Hu, Qian

    yunnan univ

  • D

    Du, Shiyu

    1 · yunnan univ

  • P

    Peng, Zhaorong

    1 · yunnan univ

  • T

    Tang, Xiaohu (通讯)

    1 · yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417